There were 1,214 press releases posted in the last 24 hours and 429,654 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
RespireRx Pharmaceuticals Inc. Announces Removal of FDA Clinical Hold on CX1739 and Initiation of Phase 2A Clinical Trial by March 31, 2016

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image